Literature DB >> 19804207

Reactive oxygen species, cell growth, cell cycle progression and vascular remodeling in hypertension.

Martina Vokurkova1, Shaoping Xu, Rhian M Touyz.   

Abstract

Reactive oxygen species (ROS) include superoxide, hygrogen peroxide and hydroxyl radical. Under physiological conditions, all vascular cell types produce ROS in a controlled and regulated fashion, mainly through nonphagocyte NADPH oxidase. An imbalance between pro-oxidants and antioxidants results in oxidative stress. ROS are important intracellular signaling molecules. There is growing evidence that increased oxidative stress and associated oxidative damage are mediators of vascular injury in hypertension, as well as in other cardiovascular diseases. Oxidative stress causes vascular injury by reducing nitric oxide bioavailability, altering endothelial function and vascular contraction/dilation, promoting vascular smooth muscle cell proliferation and hypertrophy, and increasing extracellular matrix deposition and inflammation. The present review focuses on the regulatory role of ROS on cell growth and cell cycle progression and discusses implications of these events in vascular remodeling in hypertension.

Entities:  

Year:  2007        PMID: 19804207     DOI: 10.2217/14796678.3.1.53

Source DB:  PubMed          Journal:  Future Cardiol        ISSN: 1479-6678


  3 in total

Review 1.  ROS and RNS signaling in skeletal muscle: critical signals and therapeutic targets.

Authors:  Luke P Michaelson; Colleen Iler; Christopher W Ward
Journal:  Annu Rev Nurs Res       Date:  2013

2.  A New Method to Simultaneously Quantify the Antioxidants: Carotenes, Xanthophylls, and Vitamin A in Human Plasma.

Authors:  Mariel Colmán-Martínez; Miriam Martínez-Huélamo; Esther Miralles; Ramón Estruch; Rosa M Lamuela-Raventós
Journal:  Oxid Med Cell Longev       Date:  2015-11-30       Impact factor: 6.543

Review 3.  Reactive Oxygen Species: Modulators of Phenotypic Switch of Vascular Smooth Muscle Cells.

Authors:  Adnan Badran; Suzanne A Nasser; Joelle Mesmar; Ahmed F El-Yazbi; Alessandra Bitto; Manal M Fardoun; Elias Baydoun; Ali H Eid
Journal:  Int J Mol Sci       Date:  2020-11-20       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.